Clinical Trials Logo

Dyspepsia clinical trials

View clinical trials related to Dyspepsia.

Filter by:

NCT ID: NCT01851863 Completed - Depression Clinical Trials

Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia

Start date: May 2013
Phase: Phase 4
Study type: Interventional

The study hypothesis is appropriate clinician-patient communication that provides explanations of the reasons for psychoactive drug prescriptions based on the generation of FD symptoms and the drugs' effects might improve compliance with psychoactive agent regimens among FD patients.

NCT ID: NCT01849107 Completed - Diarrhea Clinical Trials

Plasma Citrulline: A Marker for Monitoring & Quantifying Radiation-Induced Small Bowel Toxicity

Start date: April 2013
Phase: N/A
Study type: Interventional

Small bowel irradiation results in epithelial cell loss and consequently impairs function and metabolism. A metabolic end product of small bowel enterocytes is plasma citrulline. The investigators evaluate the correlation between plasma citrulline level, dose-volume histogram of small bowel, and small bowel toxicity grade by Common Terminology Criteria for Adverse Events version 4.0 (CTCAE ver.4.0) to investigate whether citrulline can be used as a biomarker for quantifying radiation-induced epithelial cell loss.

NCT ID: NCT01817465 Completed - Clinical trials for Functional Dyspepsia

A Study to Demonstrate the Efficacy and Safety of Motilitone®

Start date: August 2012
Phase: Phase 4
Study type: Interventional

This is a phase IV , comparative study to evaluate the efficacy and safety of Motiltone® in treatment of the patients with functional dyspepsia. The study is conducted with following methods: multi-centers, double blind, randomization, parallel. The subjects will receive Motilitone® or/and Pantoline®.

NCT ID: NCT01802710 Completed - Clinical trials for Psychogenic Dyspepsia

Clinical Improvement and in Quality of Life-Functional Dyspepsia-

Start date: March 2009
Phase: N/A
Study type: Interventional

Functional dyspepsia (FD)is defined as the presence of symptoms thought to originate in the gastroduodenal region with no evidence of structural disease that is likely to explain the symptoms. The cause of this condition is unclear, not being a recognized treatment for it. The conventional treatments for those patients are symptom based. Unfortunately, these medications are not very effective. Patients with FD report poorer health status, mental health, and social functioning than patients with structural gastrointestinal pathology. Our aim is to compare a combined intervention (medical plus psychological intervention) versus conventional intervention (medical intervention)in regard to the health related quality of life, symptomatology, anxiety and depression of those patients. The investigators hypothesized that compared with conventional intervention a combined intervention would yield significantly better short (after treatment) and medium term (six months after treatment) improvement of health related quality of life and symptoms.

NCT ID: NCT01737840 Completed - Dyspepsia Clinical Trials

Comparison of Pantoprazole and Ranitidine in Dyspepsia

Start date: October 2012
Phase: Phase 4
Study type: Interventional

The H0 hypothesis of the study is there is no difference between pantoprazole and ranitidine in treating patients presented with dyspepsia to the emergency department. The H1 hypothesis is there is difference between pantoprazole and ranitidine in treating patients presented with dyspepsia to the emergency department.

NCT ID: NCT01682798 Completed - Constipation Clinical Trials

Study of Yili "Changqing" Pro-ABB Yoghurt in the Improvement of Human Gastrointestinal Tract System

Start date: May 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether Yili "Chang Qing" Pro-ABB yoghurt is effective in improving mild constipation and the intestinal micro-ecology environment & alimentation.

NCT ID: NCT01677715 Completed - Constipation Clinical Trials

Study of Yili Mei Yi Tian Active Lactobacillus Drink to Improve Immunity and Digestive System

Start date: August 2011
Phase: N/A
Study type: Interventional

Study on Evaluating the Promote Effect of Yili Mei Yi Tian Active Lactobacillus Drink on Immunity and Physical Intestinal Canal

NCT ID: NCT01671670 Completed - Clinical trials for Functional Dyspepsia

Acupuncture for Patients With Function Dyspepsia

Start date: September 2012
Phase: Phase 2/Phase 3
Study type: Interventional

Hypothesis: Acupuncture is efficacious and safe for patients with functional dyspepsia Design: - A single blind randomized controlled trial - 200 participants will be included - Two arms: acupuncture and sham acupuncture group

NCT ID: NCT01670552 Completed - Dyspepsia Clinical Trials

Evaluation of Two Therapies for the Treatment of Osteoarticular Inflammation in Dyspeptic Patients

Start date: February 17, 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety of an association with one anti-inflammatory and one gastroprotective agent compared to the one anti-inflammatory and one gastroprotective agent in patients with acute or chronic osteoarticular inflammation.

NCT ID: NCT01667692 Completed - Dyspepsia Clinical Trials

Aizthromycin or Clarithromycin in H-pylori Eradication Regimen

H-pylori
Start date: March 2011
Phase: Phase 4
Study type: Interventional

The Aim of this study is comparison between two regimens containing clarithromycinand azithromycin.